Quest Diagnostics (NYSE:DGX) SVP Patrick Plewman sold 5,662 shares of the company’s stock for over $1.15 million on February 10th, reducing his ownership by 26.91%. This comes after Quest Diagnostics reported better-than-expected Q4 earnings and revenue, raised its dividend, and authorized a $1 billion share buyback program. Analysts have largely maintained “Buy” or “Hold” ratings with an average target price of $208.93.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Quest Diagnostics (NYSE:DGX) SVP Sells 5,662 Shares
Quest Diagnostics (NYSE:DGX) SVP Patrick Plewman sold 5,662 shares of the company’s stock for over $1.15 million on February 10th, reducing his ownership by 26.91%. This comes after Quest Diagnostics reported better-than-expected Q4 earnings and revenue, raised its dividend, and authorized a $1 billion share buyback program. Analysts have largely maintained “Buy” or “Hold” ratings with an average target price of $208.93.